FDAnews Drug Daily Bulletin

KAMADA AND A EUROPEAN PHARMACEUTICAL COMPANY HAVE SIGNED A FEASIBILITY PROOF MOU

May 9, 2006
A A

Kamada, a bio-pharmaceutical company which develops, manufactures and markets prescription drugs, today announced the signage of a Memorandum of Understanding with a European pharmaceutical company, one of the leading European companies in the field of plasma derived products, which debuts the collaboration between the two companies. Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060508005598&newsLang=en)